跳至主要内容
临床试验/NCT00443248
NCT00443248已完成1 期

A 2-Way Repeatability Study To Investigate Vaginal Blood Flow Before, During And After Visual Sexual Stimulation In Pre- And Post-Menopausal Women With And Without Female Sexual Arousal Disorder, Using The Heat Wash-Out Technique.

Pfizer3 个研究点 分布在 1 个国家目标入组 64 人开始时间: 2007年3月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
Pfizer
入组人数
64
试验地点
3
主要终点
To assess the safety and toleration of the heat washout device.

研究概览

简要总结

The Pfizer developed Heat Wash-Out (HWO) system is a software controlled electromechanical system designed to measure vaginal wall blood flow. A small vaginal probe is attached to a control unit. Output data are collected on a PC. By measuring the clearance of heat from the heated probe, a direct measure of absolute blood flow can be obtained. The study will assess the technique's ability to differentiate between pre- and post-menopausal women; with and without Female Sexual Arousal Disorder (FSAD).

详细描述

Medical Device Development

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Pre-menopausal women aged 18-40 (with and without FSAD) or
  • Post-menopausal women aged 50-65 (with and without FSAD.
  • FSAD must have been present for at least 6 months.

排除标准

  • Pregnant or lactating women (pre-menopausal population)
  • Systemic Hormone Replacement Therapy (HRT) or Selective Estrogen Receptor Modulator (SERM) (postmenopausal population)
  • Subjects with evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic disease or other major psychological or sexual disorder.

结局指标

主要结局

To assess the safety and toleration of the heat washout device.

时间窗: 2 weeks

To investigate differences in vaginal blood flow following visual sexual stimulation in pre-menopausal women with and without FSAD.

时间窗: 2 weeks

次要结局

  • To investigate changes in subjective acute sexual arousal following visual sexual stimulation in women with and without FSAD.(2 weeks)

研究者

发起方
Pfizer
申办方类型
Industry

研究点 (3)

Loading locations...

相似试验